Selective monitoring and treatment of neuroblastoma cells with hydrogen sulfide activatable phototheranostic agent
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Sulfur Compounds in Biology · Luminescence and Fluorescent Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (54)
Show source-provided references
1. Photodynamic therapy and anti-tumour immunity10.1038/nrc1894 ↗
2. Photodynamic therapy of cancer. Basic principles and applications10.1007/s12094-008-0172-2 ↗
3. Photodynamic therapy—an up-to-date review10.3390/app11083626 ↗
4. The role of photodynamic therapy in overcoming cancer drug resistance10.1039/c4pp00495g ↗
5. Biomodulatory approaches to photodynamic therapy for solid tumors10.1016/j.canlet.2012.07.026 ↗
6. Photodynamic therapy for cancer: role of natural products10.1016/j.pdpdt.2019.04.033 ↗
7. Activatable photosensitizers: agents for selective photodynamic therapy
8. An advanced multifunctional prodrug combining photodynamic therapy10.1016/j.dyepig.2022.110500 ↗
9. Activatable triplet photosensitizers: magic bullets for targeted photodynamic therapy10.1039/C4TC00659C ↗
10. Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy10.1021/acs.chemrev.1c00381 ↗
11. Recent advances in activatable organic photosensitizers for specific photodynamic therapy10.1002/cplu.202000203 ↗
12. Recent development of reactional small-molecule fluorescent probes based on resorufin10.1016/j.dyepig.2021.109351 ↗
13. Resorufin-based responsive probes for fluorescence and colorimetric analysis10.1039/D0TB01628D ↗
14. Resorufin enters the photodynamic therapy arena: a monoamine oxidase activatable Agent for selective cytotoxicity10.1021/acsmedchemlett.0c00484 ↗
15. A hydrogen peroxide responsive resorufin-based phototheranostic agent for selective treatment of cancer cells10.1016/j.dyepig.2021.109499 ↗
16. Locked and loaded: β-galactosidase activated photodynamic therapy agent enables selective imaging and targeted treatment of glioblastoma multiforme cancer cells10.1021/acsabm.2c00484 ↗
17. Hydrogen sulfide and cancer, chemistry, biochemistry and pharmacology of hydrogen sulfide10.1007/978-3-319-18144-8_12 ↗
18. Nitrite reductase activity and inhibition of H2S biogenesis by human cystathionine ß-synthase10.1371/journal.pone.0085544 ↗
19. Hydrogen sulfide in hypertension10.1097/MNH.0000000000000206 ↗
20. Roles of hydrogen sulfide in the pathogenesis of diabetes mellitus and its complications10.1089/ars.2011.4451 ↗
21. The role of hydrogen sulfide in gastric mucosal damage10.4103/2045-9912.260650 ↗
22. Hydrogen sulfide and the liver10.1016/j.niox.2014.02.006 ↗
23. Brain hydrogen sulfide is severely decreased in Alzheimer's disease10.1016/S0006-291X(02)00422-9 ↗
24. Characterization of hydrogen sulfide and its synthases, cystathionine β-synthase and cystathionine γ-lyase, in human prostatic tissue and cells10.1016/j.urology.2011.10.013 ↗
25. Overexpression of CBS/H2S inhibits proliferation and metastasis of colon cancer cells through downregulation of CD4410.1186/s12935-022-02512-2 ↗
26. Hydrogen sulfide attenuates opioid dependence by suppression of adenylate cyclase/cAMP pathway10.1089/ars.2012.5119 ↗
27. Small-molecule fluorescent probes for H2S detection: advances and perspectives10.1016/j.trac.2020.116117 ↗
28. Fluorescence chemosensors for hydrogen sulfide detection in biological systems10.1039/C4AN01909A ↗
29. Li · Dyes Pigments · 2021 · 18910.1016/j.dyepig.2021.109231 ↗
30. Bright chemiluminescent dioxetane probes for the detection of gaseous transmitter H2S10.1016/j.bmcl.2021.128148 ↗
31. Bioluminescence probe for detecting hydrogen sulfide in vivo10.1021/acs.analchem.5b03636 ↗
32. H2S‐activable MOF nanoparticle photosensitizer for effective photodynamic therapy against cancer with controllable singlet‐oxygen release10.1002/ange.201708005 ↗
33. Self-assembly of intelligent nanoplatform for endogenous H2S-triggered multimodal cascade therapy of colon cancer10.1021/acs.nanolett.2c01131 ↗
34. A hydrogen sulphide-responsive and depleting nanoplatform for cancer photodynamic therapy
35. A multifunctional BODIPY based fluorescent probe for hydrogen sulfide detection and photodynamic anticancer therapy in HCT116 colon cancer cell10.1016/j.dyepig.2021.109897 ↗
36. Neuroblastoma: biology, prognosis, and treatment10.1016/j.hoc.2009.11.011 ↗
37. Recent advances in neuroblastoma10.1056/NEJMra0804577 ↗
38. Pediatric neuroblastomas: genetic and epigenetic ‘danse macabre10.1016/j.gene.2003.09.042 ↗
39. Neuroblastoma genetics and phenotype: a tale of heterogeneity10.1016/j.semcancer.2011.07.003 ↗
40. The international neuroblastoma pathology classification (the Shimada system)10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7 ↗
41. Neuroblastoma
42. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas10.1056/NEJM198510313131802 ↗
43. Advances in the diagnosis and treatment of neuroblastoma10.1634/theoncologist.8-3-278 ↗
44. Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy
45. Drug resistance in human neuroblastoma cell lines correlates with clinical therapy10.1016/S0959-8049(97)00213-X ↗
46. Characterization of drug-resistant neuroblastoma cell lines by comparative genomic hybridization
47. Neuroglobin and cytoglobin overexpression protects human SH-SY5Y neuroblastoma cells against oxidative stress-induced cell death10.1016/j.neulet.2006.09.027 ↗
48. The role of photodynamic therapy in overcoming cancer drug resistance10.1039/c4pp00495g ↗
49. A ratiometric fluorescent probe for hydrogen sulfide imaging in living cells10.1016/j.talanta.2014.01.001 ↗
50. Steady‐state near‐infrared detection of singlet molecular oxygen: a Stern‐Volmer quenching experiment with sodium azide10.1111/j.1751-1097.1987.tb05403.x ↗
51. ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors10.1042/BJ20130282 ↗
52. Hydrogen sulfide is essential for Schwann cell responses to peripheral nerve injury10.1111/jnc.12932 ↗
53. Hydrogen sulfide signalling in Mitochondria and disease10.1096/fj.201901304R ↗
54. A mitochondria-targeted cryptocyanine-based photothermogenic photosensitizer10.1021/jacs.7b04263 ↗